BlackRock Inc. Invests $3.41 Million in WillScot Corp (NASDAQ:WSC)

BlackRock Inc. acquired a new position in WillScot Corp (NASDAQ:WSC) in the 1st quarter, according to its most recent 13F filing with the Securities …

WillScot logoBlackRock Inc. acquired a new position in WillScot Corp (NASDAQ:WSC) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 249,946 shares of the company’s stock, valued at approximately $3,412,000. BlackRock Inc. owned approximately 0.30% of WillScot at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Northern Trust Corp purchased a new position in WillScot in the first quarter valued at $567,000. Wells Fargo & Company MN acquired a new position in WillScot in the 4th quarter valued at about $600,000. Finally, Schwab Charles Investment Management Inc. acquired a new position in WillScot in the 1st quarter valued at about $1,520,000. Hedge funds and other institutional investors own 37.15% of the company’s stock.

WSC has been the topic of several recent analyst reports. Zacks Investment Research lowered shares of WillScot from a “hold” rating to a “sell” rating in a report on Thursday, May 10th. ValuEngine raised shares of WillScot from a “sell” rating to a “hold” rating in a research note on Tuesday, June 5th. Jefferies Financial Group assumed coverage on shares of WillScot in a research note on Monday, July 9th. They set a “buy” rating on the stock. Finally, Credit Suisse Group assumed coverage on shares of WillScot in a research report on Friday. They issued an “outperform” rating and a $20.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $16.50.

Shares of WSC opened at $16.00 on Friday. The company has a quick ratio of 0.80, a current ratio of 0.86 and a debt-to-equity ratio of 1.44. The stock has a market capitalization of $1.50 billion and a PE ratio of -4.13. WillScot Corp has a 52-week low of $9.45 and a 52-week high of $17.70.

WillScot (NASDAQ:WSC) last posted its earnings results on Tuesday, August 7th. The company reported $0.05 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.01 by $0.04. The business had revenue of $140.33 million for the quarter, compared to analysts’ expectations of $144.55 million. equities research analysts forecast that WillScot Corp will post 0.07 EPS for the current fiscal year.

WillScot Profile

WillScot Corporation, through its subsidiaries, provides various specialty rental services in the United States, Canada, and Mexico. It is involved in the leasing and sale of mobile offices, modular buildings, and storage products. The company offers various modular space units, including panelized and stackable offices, single-wide modular space units, section modulars and redi-plex complexes, classrooms, container offices, and other modular spaces; and portable storage units, such as shipping containers with swing doors.

Featured Article: Closed-End Mutual Funds (CEFs)

Institutional Ownership by Quarter for WillScot (NASDAQ:WSC)

Receive News & Ratings for WillScot Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for WillScot and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

ConforMIS Inc (CFMS) Shares Bought by BlackRock Inc.

BlackRock Inc. lifted its stake in ConforMIS Inc (NASDAQ:CFMS) by 2.6% in the 1st quarter, according to its most recent filing with the Securities and …

ConforMIS logoBlackRock Inc. lifted its stake in ConforMIS Inc (NASDAQ:CFMS) by 2.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,398,722 shares of the medical instruments supplier’s stock after purchasing an additional 61,539 shares during the period. BlackRock Inc. owned 3.94% of ConforMIS worth $3,478,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of CFMS. Two Sigma Investments LP acquired a new stake in ConforMIS in the 4th quarter valued at approximately $130,000. Schwab Charles Investment Management Inc. raised its position in ConforMIS by 93.2% in the 1st quarter. Schwab Charles Investment Management Inc. now owns 140,943 shares of the medical instruments supplier’s stock valued at $205,000 after buying an additional 68,000 shares during the last quarter. Deutsche Bank AG raised its position in ConforMIS by 43.5% in the 4th quarter. Deutsche Bank AG now owns 120,849 shares of the medical instruments supplier’s stock valued at $286,000 after buying an additional 36,634 shares during the last quarter. Northern Trust Corp raised its position in ConforMIS by 20.2% in the 1st quarter. Northern Trust Corp now owns 538,985 shares of the medical instruments supplier’s stock valued at $782,000 after buying an additional 90,447 shares during the last quarter. Finally, Renaissance Technologies LLC raised its position in ConforMIS by 627.0% in the 4th quarter. Renaissance Technologies LLC now owns 346,800 shares of the medical instruments supplier’s stock valued at $825,000 after buying an additional 299,100 shares during the last quarter. Hedge funds and other institutional investors own 42.60% of the company’s stock.

CFMS has been the topic of several recent analyst reports. ValuEngine raised ConforMIS from a “strong sell” rating to a “sell” rating in a research report on Wednesday, May 2nd. BTIG Research reaffirmed a “buy” rating and set a $3.00 price target on shares of ConforMIS in a research report on Thursday, May 3rd. Oppenheimer set a $4.00 price target on ConforMIS and gave the stock a “buy” rating in a research report on Thursday, May 3rd. Zacks Investment Research raised ConforMIS from a “hold” rating to a “buy” rating and set a $1.50 price target on the stock in a research report on Wednesday, June 20th. Finally, SunTrust Banks reiterated a “buy” rating on shares of ConforMIS in a research note on Monday, July 16th. One analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $3.25.

CFMS opened at $0.91 on Friday. The firm has a market capitalization of $61.28 million, a P/E ratio of -0.73 and a beta of 0.90. ConforMIS Inc has a 1 year low of $0.88 and a 1 year high of $4.17. The company has a quick ratio of 4.15, a current ratio of 4.77 and a debt-to-equity ratio of 0.60.

ConforMIS (NASDAQ:CFMS) last released its quarterly earnings results on Friday, August 3rd. The medical instruments supplier reported ($0.24) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.21) by ($0.03). The firm had revenue of $19.10 million during the quarter, compared to the consensus estimate of $19.52 million. ConforMIS had a negative net margin of 64.66% and a negative return on equity of 94.69%. research analysts expect that ConforMIS Inc will post -0.83 EPS for the current fiscal year.

ConforMIS Company Profile

ConforMIS, Inc, a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a customized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee.

Featured Story: Market Capitalization

Institutional Ownership by Quarter for ConforMIS (NASDAQ:CFMS)

Receive News & Ratings for ConforMIS Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for ConforMIS and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Amalgamated Bank Increases Position in Healthequity Inc (HQY)

WINTON GROUP Ltd bought a new stake in shares of Healthequity in the first quarter worth about $206,000. Finally, Parametrica Management Ltd …

Healthequity logoAmalgamated Bank lifted its position in Healthequity Inc (NASDAQ:HQY) by 21.1% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,792 shares of the company’s stock after purchasing an additional 1,534 shares during the quarter. Amalgamated Bank’s holdings in Healthequity were worth $660,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of HQY. Citigroup Inc. increased its holdings in shares of Healthequity by 414.4% in the first quarter. Citigroup Inc. now owns 2,639 shares of the company’s stock worth $160,000 after purchasing an additional 2,126 shares during the last quarter. Cim LLC bought a new stake in shares of Healthequity in the second quarter worth about $204,000. M&T Bank Corp bought a new stake in shares of Healthequity in the first quarter worth about $206,000. WINTON GROUP Ltd bought a new stake in shares of Healthequity in the first quarter worth about $206,000. Finally, Parametrica Management Ltd bought a new stake in shares of Healthequity in the first quarter worth about $220,000. 95.38% of the stock is currently owned by hedge funds and other institutional investors.

In other Healthequity news, VP Darcy G. Mott sold 9,500 shares of the business’s stock in a transaction that occurred on Monday, May 21st. The stock was sold at an average price of $73.93, for a total transaction of $702,335.00. Following the completion of the transaction, the vice president now owns 111,500 shares in the company, valued at $8,243,195. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Frank Medici sold 6,904 shares of the business’s stock in a transaction that occurred on Friday, July 13th. The shares were sold at an average price of $80.40, for a total value of $555,081.60. Following the transaction, the director now owns 17,649 shares of the company’s stock, valued at approximately $1,418,979.60. The disclosure for this sale can be found here. In the last quarter, insiders sold 57,100 shares of company stock valued at $4,457,965. 4.00% of the stock is currently owned by company insiders.

Several brokerages have recently issued reports on HQY. KeyCorp lifted their target price on Healthequity from $82.00 to $90.00 and gave the stock a “buy” rating in a report on Thursday, July 19th. Zacks Investment Research raised Healthequity from a “sell” rating to a “hold” rating in a report on Friday, July 20th. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $68.00 target price (up from $65.00) on shares of Healthequity in a report on Monday, June 4th. ValuEngine upgraded Healthequity from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, May 22nd. Finally, SunTrust Banks lifted their price target on Healthequity from $70.00 to $85.00 and gave the stock a “buy” rating in a research report on Tuesday, June 5th. Three investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $77.73.

HQY opened at $87.05 on Friday. The stock has a market capitalization of $5.12 billion, a P/E ratio of 161.78, a P/E/G ratio of 3.43 and a beta of 1.37. Healthequity Inc has a 12 month low of $40.21 and a 12 month high of $88.30.

Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Monday, June 4th. The company reported $0.31 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.22 by $0.09. The company had revenue of $69.90 million during the quarter, compared to analyst estimates of $68.81 million. Healthequity had a return on equity of 13.47% and a net margin of 22.91%. The firm’s revenue was up 26.2% on a year-over-year basis. During the same quarter last year, the business posted $0.23 earnings per share. analysts expect that Healthequity Inc will post 0.72 EPS for the current year.

About Healthequity

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading: Diversification in Your Portfolio

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Healthequity and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

BlackRock Inc. Reduces Holdings in Triangle Capital Co. (TCAP)

BlackRock Inc. decreased its stake in Triangle Capital Co. (NYSE:TCAP) by 13.8% in the 1st quarter, according to its most recent Form 13F filing with …

Triangle Capital logoBlackRock Inc. decreased its stake in Triangle Capital Co. (NYSE:TCAP) by 13.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 263,092 shares of the credit services provider’s stock after selling 42,295 shares during the period. BlackRock Inc. owned approximately 0.55% of Triangle Capital worth $2,928,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Advisor Group Inc. raised its position in shares of Triangle Capital by 176.2% in the fourth quarter. Advisor Group Inc. now owns 11,453 shares of the credit services provider’s stock valued at $110,000 after buying an additional 7,307 shares during the last quarter. Bank of New York Mellon Corp acquired a new position in shares of Triangle Capital in the fourth quarter valued at approximately $113,000. Trexquant Investment LP purchased a new stake in Triangle Capital in the first quarter valued at approximately $165,000. Jane Street Group LLC purchased a new stake in Triangle Capital in the fourth quarter valued at approximately $199,000. Finally, Goldman Sachs Group Inc. purchased a new stake in Triangle Capital in the fourth quarter valued at approximately $536,000. Institutional investors own 50.10% of the company’s stock.

A number of research firms recently issued reports on TCAP. Zacks Investment Research upgraded shares of Triangle Capital from a “sell” rating to a “buy” rating and set a $13.00 target price for the company in a report on Wednesday, June 20th. ValuEngine downgraded shares of Triangle Capital from a “buy” rating to a “hold” rating in a research note on Wednesday, May 2nd. Finally, National Securities reiterated a “neutral” rating and set a $13.00 price objective on shares of Triangle Capital in a research note on Monday, May 7th. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $12.90.

TCAP remained flat at $$11.80 during trading on Friday. The company has a market cap of $571.32 million, a P/E ratio of 7.61 and a beta of 0.75. The company has a quick ratio of 116.18, a current ratio of 116.18 and a debt-to-equity ratio of 0.83. Triangle Capital Co. has a twelve month low of $8.91 and a twelve month high of $16.44.

The business also recently declared a special dividend, which was paid on Friday, August 3rd. Investors of record on Thursday, August 2nd were issued a $1.78 dividend. The ex-dividend date was Monday, August 6th. This is a boost from Triangle Capital’s previous special dividend of $0.05. Triangle Capital’s dividend payout ratio is currently 77.42%.

Triangle Capital Company Profile

Triangle Capital Corporation is a business development company specializing in private equity and mezzanine investments. It focuses on leveraged buyouts, management buyouts, ESOPs, change of control transactions, acquisition financings, growth financing, and recapitalizations in lower middle market, mature, and later stage companies.

Read More: Earnings Per Share

Institutional Ownership by Quarter for Triangle Capital (NYSE:TCAP)

Receive News & Ratings for Triangle Capital Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Triangle Capital and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

BlackRock Inc. Sells 99570 Shares of PC Tel Inc (PCTI)

BlackRock Inc. trimmed its stake in PC Tel Inc (NASDAQ:PCTI) by 16.5% during the first quarter, according to its most recent 13F filing with the …

PC Tel logoBlackRock Inc. trimmed its stake in PC Tel Inc (NASDAQ:PCTI) by 16.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 503,375 shares of the Wireless communications provider’s stock after selling 99,570 shares during the period. BlackRock Inc. owned approximately 2.75% of PC Tel worth $3,614,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Millennium Management LLC purchased a new stake in PC Tel in the fourth quarter valued at approximately $118,000. Raymond James & Associates purchased a new stake in PC Tel in the fourth quarter valued at approximately $510,000. Bank of New York Mellon Corp grew its holdings in PC Tel by 403.0% in the fourth quarter. Bank of New York Mellon Corp now owns 103,494 shares of the Wireless communications provider’s stock valued at $764,000 after purchasing an additional 82,917 shares during the period. Finally, Renaissance Technologies LLC grew its holdings in PC Tel by 0.8% in the fourth quarter. Renaissance Technologies LLC now owns 1,478,515 shares of the Wireless communications provider’s stock valued at $10,897,000 after purchasing an additional 11,962 shares during the period. 83.69% of the stock is currently owned by hedge funds and other institutional investors.

A number of equities research analysts recently issued reports on the stock. TheStreet downgraded shares of PC Tel from a “b” rating to a “c+” rating in a report on Monday, July 9th. Zacks Investment Research downgraded shares of PC Tel from a “hold” rating to a “sell” rating in a report on Wednesday. Lake Street Capital downgraded shares of PC Tel from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $9.00 to $6.00 in a research note on Thursday, August 9th. B. Riley upgraded shares of PC Tel from a “neutral” rating to a “buy” rating and decreased their price objective for the stock from $8.50 to $4.50 in a research note on Thursday, August 9th. Finally, ValuEngine downgraded shares of PC Tel from a “hold” rating to a “sell” rating in a research note on Tuesday, July 10th. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a buy rating to the company’s stock. PC Tel currently has a consensus rating of “Hold” and an average price target of $6.25.

Shares of NASDAQ PCTI traded down $0.09 during trading on Friday, reaching $4.18. 24,500 shares of the stock were exchanged, compared to its average volume of 34,464. PC Tel Inc has a twelve month low of $4.12 and a twelve month high of $7.85. The stock has a market cap of $81.32 million, a P/E ratio of 41.80 and a beta of 0.51.

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 15th. Investors of record on Wednesday, August 8th were issued a $0.055 dividend. The ex-dividend date was Tuesday, August 7th. This represents a $0.22 annualized dividend and a yield of 5.26%. PC Tel’s dividend payout ratio is presently 220.00%.

PC Tel Company Profile

PCTEL, Inc, together with its subsidiaries, delivers performance critical telecom solutions in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. The company operates in two segments, Connected Solutions and RF Solutions. The Connected Solutions segment designs and delivers precision antennas, which are used primarily in small cells, enterprise Wi-Fi access points, fleet management and transit systems, and in equipment and devices for the Industrial Internet of Things.

Read More: Earnings Per Share

Institutional Ownership by Quarter for PC Tel (NASDAQ:PCTI)

Receive News & Ratings for PC Tel Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for PC Tel and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts